Principal Investigator

David Walling, Ph.D.

Collaborative Neuroscience Research - Garden Grove

  • 2 trials
  • 2 recruiting now
  • 1 compound

Therapeutic focus

  • Major Depressive Disorder (MDD)
  • Major Depressive Disorder With Anxious Distress
  • Major Depressive Disorder

Recruiting now (2)

NCTPhaseStatusCompoundSponsor
NCT07161700Phase 2Recruiting—
NCT07065240Phase 2RecruitingGlyphAllo (SPT-300)

All trials (2)

NCTPhaseStatusCompoundSponsor
NCT07161700Phase 2Recruiting—
NCT07065240Phase 2RecruitingGlyphAllo (SPT-300)

Compounds studied

Trial sites (40)

  • Leszno, Poland
  • Garden Grove, California, United States
  • Rimavská Sobota, Slovakia
  • Everett, Washington, United States
  • Chemnitz, Germany
  • Russells Mills, Massachusetts, United States
  • Jacksonville, Florida, United States
  • Allentown, Pennsylvania, United States
  • Chino, California, United States
  • Cedarhurst, New York, United States
  • Dallas, Texas, United States
  • Gdansk, Poland
  • Bratislava, Slovakia
  • San Jose, California, United States
  • Pilsen, Czechia
  • Sofia, Bulgaria
  • Bydgoszcz, Poland
  • Decatur, Georgia, United States
  • Katowice, Poland
  • Wroclaw, Poland
  • Irving, Texas, United States
  • Berlin, Brandenburg, Germany
  • Schwerin, Mecklenburg-Vorpommern, Germany
  • Warsaw, Poland
  • St Louis, Missouri, United States
  • Boston, Massachusetts, United States
  • Palm Bay, Florida, United States
  • Richardson, Texas, United States
  • Lauderhill, Florida, United States
  • Cromwell, Connecticut, United States
  • Staten Island, New York, United States
  • Vranov nad Topľou, Slovakia
  • Orlando, Florida, United States
  • Budapest, Hungary
  • Marietta, Georgia, United States
  • Glendale, California, United States
  • Independence, Ohio, United States
  • Bad Homburg, Germany
  • Bełchatów, Poland
  • Brno, Czechia

Investigator and site data mirrored fromClinicalTrials.gov (public domain).